Angiodroid Revenue and Competitors
Estimated Revenue & Valuation
- Angiodroid's estimated annual revenue is currently $13.1M per year.
- Angiodroid's estimated revenue per employee is $251,000
Employee Data
- Angiodroid has 52 Employees.
- Angiodroid grew their employee count by 13% last year.
Angiodroid's People
| Name | Title | Email/Phone |
|---|
Angiodroid Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Angiodroid?
Angiodroid Srl is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector: • 100 % automatic • 100 % safe • 100 % digital • 100 % user friendly More info at www.angiodroid.com
keywords:N/A
N/A
Total Funding
52
Number of Employees
$13.1M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator